Monopar Therapeutics Inc. (MNPR)
NASDAQ: MNPR · Real-Time Price · USD
110.33
-0.49 (-0.44%)
Aug 26, 2026, 10:49 AM EDT - Market open
Monopar Therapeutics Analyst Ratings
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Morgan Stanley | Morgan Stanley | Buy Reiterates $115 → $130 | Buy | Reiterates | $115 → $130 | +17.83% | Aug 17, 2026 |
| H.C. Wainwright | H.C. Wainwright | Buy Reiterates $125 | Buy | Reiterates | $125 | +13.30% | Aug 13, 2026 |
| Cantor Fitzgerald | Cantor Fitzgerald | Hold Downgrades $109 → $119 | Hold | Downgrades | $109 → $119 | +7.86% | Aug 13, 2026 |
| Barclays | Barclays | Buy Maintains $125 → $128 | Buy | Maintains | $125 → $128 | +16.02% | Aug 13, 2026 |
| JonesTrading | JonesTrading | Buy Maintains $130 | Buy | Maintains | $130 | +17.83% | Aug 12, 2026 |
| BTIG | BTIG | Buy Maintains $117 → $133 | Buy | Maintains | $117 → $133 | +20.55% | Aug 12, 2026 |
| Lake Street | Lake Street | Buy Maintains $103 | Buy | Maintains | $103 | -6.64% | Jun 30, 2026 |
| Piper Sandler | Piper Sandler | Buy Maintains $101 | Buy | Maintains | $101 | -8.46% | Jun 29, 2026 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 3 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.